Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3754030aa1e08d94474be9c5dd299f50 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-56 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56 |
filingDate |
2009-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09e1bc85fdab27d24b73a7d57408e379 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4f39873c8ebf5ebeb2ba50894c3bef0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90aca4886e3799f418bc346bda69c46a |
publicationDate |
2009-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009208988-A1 |
titleOfInvention |
Protocol and Apparatus for Determining Heparin-induced Thrombocytopenia |
abstract |
A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit determination of heparin-induced thrombocytopenia II complex (HiT II). |
priorityDate |
2003-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |